Pfizer Enodia Therapeutics Deal: $500M+ Sec61 Pact
Pfizer Enodia Therapeutics deal: a Sec61 inhibitor collaboration worth over $500M in potential value. Upfront undisclosed; discovery stage only.
Pfizer Enodia Therapeutics deal: a Sec61 inhibitor collaboration worth over $500M in potential value. Upfront undisclosed; discovery stage only.